Sometimes we can manage eye problems with closer monitoring, laser treatment, or injections while you continue your GLP-1 medication
Cline JM, Soderqvist G, von Schoultz E, Skoog L, von Schoultz B
Others are more conservative due to concerns about the high costs, access issues, side effects, and lack of longitudinal data on long-term outcomes
If your provider hasn't addressed eating disorders or your mental health history, ask directly: "Have I been screened for eating disorders before starting this medication?" Request a referral if needed
Effectively managing these comorbidities is crucial for overall health and well-being
It binds to glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors hormones that stimulate insulin secretion and suppress appetite